Clinical trial
A Multicenter Randomized Double-blind Placebo-controlled Parallel Group Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 Cream Used in the Treatment of Mild to Moderate Plaque Psoriasis
NCT05706870 is registered in ClinicalTrials.gov with GEN İlaç ve Sağlık Ürünleri A.Ş. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Randomized Double-blind Placebo-controlled Parallel Group Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 Cream Used in the Treatment of Mild to Moderate Plaque Psoriasis
- Lead sponsor
- GEN İlaç ve Sağlık Ürünleri A.Ş.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 7, 2022
- Completion date
- March 3, 2024
- Enrollment
- 190 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.